Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer

J. S. Lee, S. Park, J. M. Park, J. H. Cho, S. I. Kim, B. W. Park

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Background: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), in breast cancers. Patients and methods: Preoperative CA 15-3 and CEA levels of 1681 patients were measured. The association of both tumor markers levels with clinicopathological parameters and outcomes was investigated by univariate and multivariate analyses. Results: Among 1681 patients, elevated preoperative CA15-3 and CEA levels were identified in 176 and 131 patients, respectively. Higher preoperative CA 15-3 and CEA levels were significantly associated with a larger tumor size, axillary node metastases, and advanced stage. Patients with elevated CA 15-3 and CEA levels showed worse survival, even in stage-matched analysis. Patients with normal levels of both CA15-3 and CEA showed better survival than those with one or both markers levels elevated. In multivariate analysis, elevated preoperative CA 15-3 and CEA levels were independent prognostic factors. The statistical significance of elevated preoperative tumor markers levels on survival was solidified with longer follow-up and larger study population. Conclusions: Elevated preoperative CA 15-3 and CEA levels are associated with tumor burden and showed independent prognostic significance. Therefore, new treatment strategies are necessary for patients with elevated preoperative CA 15-3 and CEA levels in clinical practice.

Original languageEnglish
Article numbermds604
Pages (from-to)1225-1231
Number of pages7
JournalAnnals of Oncology
Volume24
Issue number5
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Carcinoembryonic Antigen
Breast Neoplasms
Antigens
Serum
Neoplasms
Tumor Biomarkers
Survival
Multivariate Analysis
Differentiation Antigens
Tumor Burden
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Lee, J. S. ; Park, S. ; Park, J. M. ; Cho, J. H. ; Kim, S. I. ; Park, B. W. / Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer. In: Annals of Oncology. 2013 ; Vol. 24, No. 5. pp. 1225-1231.
@article{fcaecb76f5864e72a3e56783a2a2004f,
title = "Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer",
abstract = "Background: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), in breast cancers. Patients and methods: Preoperative CA 15-3 and CEA levels of 1681 patients were measured. The association of both tumor markers levels with clinicopathological parameters and outcomes was investigated by univariate and multivariate analyses. Results: Among 1681 patients, elevated preoperative CA15-3 and CEA levels were identified in 176 and 131 patients, respectively. Higher preoperative CA 15-3 and CEA levels were significantly associated with a larger tumor size, axillary node metastases, and advanced stage. Patients with elevated CA 15-3 and CEA levels showed worse survival, even in stage-matched analysis. Patients with normal levels of both CA15-3 and CEA showed better survival than those with one or both markers levels elevated. In multivariate analysis, elevated preoperative CA 15-3 and CEA levels were independent prognostic factors. The statistical significance of elevated preoperative tumor markers levels on survival was solidified with longer follow-up and larger study population. Conclusions: Elevated preoperative CA 15-3 and CEA levels are associated with tumor burden and showed independent prognostic significance. Therefore, new treatment strategies are necessary for patients with elevated preoperative CA 15-3 and CEA levels in clinical practice.",
author = "Lee, {J. S.} and S. Park and Park, {J. M.} and Cho, {J. H.} and Kim, {S. I.} and Park, {B. W.}",
year = "2013",
month = "5",
day = "1",
doi = "10.1093/annonc/mds604",
language = "English",
volume = "24",
pages = "1225--1231",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "5",

}

Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer. / Lee, J. S.; Park, S.; Park, J. M.; Cho, J. H.; Kim, S. I.; Park, B. W.

In: Annals of Oncology, Vol. 24, No. 5, mds604, 01.05.2013, p. 1225-1231.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer

AU - Lee, J. S.

AU - Park, S.

AU - Park, J. M.

AU - Cho, J. H.

AU - Kim, S. I.

AU - Park, B. W.

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Background: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), in breast cancers. Patients and methods: Preoperative CA 15-3 and CEA levels of 1681 patients were measured. The association of both tumor markers levels with clinicopathological parameters and outcomes was investigated by univariate and multivariate analyses. Results: Among 1681 patients, elevated preoperative CA15-3 and CEA levels were identified in 176 and 131 patients, respectively. Higher preoperative CA 15-3 and CEA levels were significantly associated with a larger tumor size, axillary node metastases, and advanced stage. Patients with elevated CA 15-3 and CEA levels showed worse survival, even in stage-matched analysis. Patients with normal levels of both CA15-3 and CEA showed better survival than those with one or both markers levels elevated. In multivariate analysis, elevated preoperative CA 15-3 and CEA levels were independent prognostic factors. The statistical significance of elevated preoperative tumor markers levels on survival was solidified with longer follow-up and larger study population. Conclusions: Elevated preoperative CA 15-3 and CEA levels are associated with tumor burden and showed independent prognostic significance. Therefore, new treatment strategies are necessary for patients with elevated preoperative CA 15-3 and CEA levels in clinical practice.

AB - Background: To evaluate the prognostic value of preoperative tumor markers, cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA), in breast cancers. Patients and methods: Preoperative CA 15-3 and CEA levels of 1681 patients were measured. The association of both tumor markers levels with clinicopathological parameters and outcomes was investigated by univariate and multivariate analyses. Results: Among 1681 patients, elevated preoperative CA15-3 and CEA levels were identified in 176 and 131 patients, respectively. Higher preoperative CA 15-3 and CEA levels were significantly associated with a larger tumor size, axillary node metastases, and advanced stage. Patients with elevated CA 15-3 and CEA levels showed worse survival, even in stage-matched analysis. Patients with normal levels of both CA15-3 and CEA showed better survival than those with one or both markers levels elevated. In multivariate analysis, elevated preoperative CA 15-3 and CEA levels were independent prognostic factors. The statistical significance of elevated preoperative tumor markers levels on survival was solidified with longer follow-up and larger study population. Conclusions: Elevated preoperative CA 15-3 and CEA levels are associated with tumor burden and showed independent prognostic significance. Therefore, new treatment strategies are necessary for patients with elevated preoperative CA 15-3 and CEA levels in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84877152314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877152314&partnerID=8YFLogxK

U2 - 10.1093/annonc/mds604

DO - 10.1093/annonc/mds604

M3 - Article

C2 - 23230137

AN - SCOPUS:84877152314

VL - 24

SP - 1225

EP - 1231

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 5

M1 - mds604

ER -